Will Congress extend ACA enhanced premium subsidies before Q4 2026?

Four months past expiration with zero management mention of pending legislation and no new positive catalyst data. Management's 2027-cycle caution language and Marketplace downsizing plan (62% contraction from 655K to 250K) are both planned as if no restoration occurs. The same Congressional majority that enacted OBBBA would need to reverse course on a Biden-era ARPA provision — historical base rate for that pattern is low absent majority change. Pre-November election window is open but double-edged — parties may prefer campaigning on the issue.

Management silence on Q1 call is moderately strong negative signal given Marketplace materiality. If Congressional action were probable, lobbying or scenario planning commentary would be expected. However, mid-term election cycle can generate last-minute appropriations or healthcare packages that bundle extensions. The RAPID impact timeline (1-2 quarter flow-through) means even a late-cycle extension would register before resolution. Absence of catalyst data in Q1 modestly lowers prior from 22% but doesn't warrant dramatic revision given political tail possibilities.

Prior 22% reflected a balanced assessment of the political environment. Q1 earnings update adds no positive catalyst but also no decisive negative trigger beyond confirmed management planning. The absence of mention on a call focused on operational matters is not strictly definitive — companies rarely comment on pending legislation they don't influence. Political handicapping carries significant epistemic uncertainty that no internal analysis can reduce; prior should be maintained absent clear new signal.

The political window is narrowing as resolution approaches. With ~6 months to Oct 15, 2026, Congress would need to pass and the President would need to sign legislation. The current majority enacted OBBBA — the structural contraction of safety net programs — making restoration of ARPA-era enhanced subsidies politically incongruous. Management's complete Q1 silence combined with 2027-cycle caution language suggests they see no probability-weighted reason to signal optimism. Slight downward revision from 22% prior.

Election-year dynamics can produce unexpected legislative action — continuing resolutions, appropriations packages, or healthcare bundled legislation often pass in September/October of election years. The enhanced subsidies were popular (benefited ~20M enrollees) and their expiration generates rate shock stories during open enrollment November 2026 — a political pressure point for the incumbent majority. Counterbalancing: OBBBA passage showed the majority was willing to accept such political costs. Keeping close to prior 22% with slight upward bias on election-year legislative activity.

Molina itself is structurally exiting the Marketplace dependency — 62% membership contraction is now the operational baseline, and Q1 MCR improved materially to 84% in a smaller, higher-premium pool. This operational adaptation reduces MOH's leverage on the question (they no longer desperately need restoration) which may correlate with reduced industry lobbying intensity. Combined with 4 months of Congressional silence and no bipartisan framework discussion, probability should edge below prior. Not a large move — political tails remain.

No mention of ACA subsidy extension on Q1 2026 earnings call. Management planning Marketplace contraction without restoration assumption. Political majority that passed OBBBA unlikely to reverse course. Slightly lower than 22% prior.

No new catalyst either direction since 2026-02-05 prior. 22% baseline reasonable given political environment. Open enrollment rate shock could pressure Congress pre-election, but also possibly after Oct 15 resolution date.

6 months to resolution, no legislation introduced, no management commentary, no bipartisan framework. Historical base rate for restoring expired subsidies under hostile majority is low. Slight downward adjustment from 22%.